PITTSBURGH, March 21 /PRNewswire/ -- Dr. Doros Platika, M.D., President and Chief Executive Officer of The Pittsburgh Life Sciences Greenhouse (PLSG), the private/public partnership putting the region’s life sciences industry on a fast track for growth, today announced PLSG has invested $100,000 in Cohera Medical, Inc., which has developed a non-toxic adhesive called TissueGlu(TM), which is biodegradable and absorbed into the body as surgical wounds heal. The investment is provided under the PLSG’s Technology Development Fund (TDF) program.
“Cohera Medical, Inc. TissueGlu(TM), which is currently in pre-clinical trials, will enhance the healing and recovery process after surgery for the full range of surgical procedures,” said Patrick Daly, President and Chief Executive Officer of Cohera Medical, Inc. “Cohera is excited to be one of many companies from the Pittsburgh life sciences community ready to establish a strong national and international presence. Our focus is to develop products that doctors will utilize to improve patient outcomes.”
About the Technology Development Fund (TDF)
The Technology Development Fund is a competitive funding program designed to increase the commercialization potential of life science technologies developed by the region’s scientists and entrepreneurs. The intent is to provide financial support to verify the technical and commercial feasibility of early stage inventions that will accelerate and increase the likelihood that the technology will be successfully commercialized through a regional start-up company. These funds can be used in conjunction with or to leverage other early sources of funding.
About the PLSG
The Pittsburgh Life Sciences Greenhouse is a public/private partnership, founded by the University of Pittsburgh, Carnegie Mellon University, UPMC Health System, the Commonwealth of Pennsylvania and its regional foundation community. Together with private industry and advanced research and healthcare capabilities of our institutional partners, PLSG invests in and supports the growth of regional life sciences companies in the areas of: bioinformatics; bionanotechnology; diagnostics; medical devices; medical robotics; therapeutics; and tools and services.
Pittsburgh Life Sciences Greenhouse
CONTACT: Tim O’Brien of O’Brien Communications, +1-412-854-8845; or LynnBanaszak Brusco of Pittsburgh Life Sciences Greenhouse, +1-412-770-1353
Web site: http://www.plsg.com/
